Personal tools

Coexpression cluster:C2050: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 3: Line 3:
|gostat_on_coexpression_clusters=GO:0007379!segment specification!0.0100654842000056!648$GO:0048146!positive regulation of fibroblast proliferation!0.0100654842000056!648$GO:0048144!fibroblast proliferation!0.0100654842000056!648$GO:0048145!regulation of fibroblast proliferation!0.0100654842000056!648$GO:0035282!segmentation!0.0156537320258094!648$GO:0009880!embryonic pattern specification!0.0156537320258094!648$GO:0003002!regionalization!0.0416538239019674!648
|gostat_on_coexpression_clusters=GO:0007379!segment specification!0.0100654842000056!648$GO:0048146!positive regulation of fibroblast proliferation!0.0100654842000056!648$GO:0048144!fibroblast proliferation!0.0100654842000056!648$GO:0048145!regulation of fibroblast proliferation!0.0100654842000056!648$GO:0035282!segmentation!0.0156537320258094!648$GO:0009880!embryonic pattern specification!0.0156537320258094!648$GO:0003002!regionalization!0.0416538239019674!648
|id=C2050
|id=C2050
|ontology_enrichment_celltype=
|ontology_enrichment_disease=DOID:8692!7.72e-12!31;DOID:1240!2.11e-09!39;DOID:2531!8.21e-08!51;DOID:0060083!8.21e-08!51
|ontology_enrichment_uberon=UBERON:0007023!6.40e-07!115
}}
}}

Revision as of 14:19, 21 May 2012


Full id: C2050_chronic_acute_prostate_large_Mast_nonsmall_breast



Phase1 CAGE Peaks

Hg19::chr10:22605374..22605387,+p2@COMMD3
p4@BMI1
Hg19::chr10:22605396..22605408,+p3@COMMD3
p9@BMI1
Hg19::chr10:22605437..22605446,+p14@BMI1
p4@COMMD3
Hg19::chr10:22610271..22610284,+p7@BMI1


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0007379segment specification0.0100654842000056
GO:0048146positive regulation of fibroblast proliferation0.0100654842000056
GO:0048144fibroblast proliferation0.0100654842000056
GO:0048145regulation of fibroblast proliferation0.0100654842000056
GO:0035282segmentation0.0156537320258094
GO:0009880embryonic pattern specification0.0156537320258094
GO:0003002regionalization0.0416538239019674



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br>disease_data<br>


Uber Anatomy
Ontology termp-valuen
adult organism6.40e-07115
Disease
Ontology termp-valuen
myeloid leukemia7.72e-1231
leukemia2.11e-0939
hematologic cancer8.21e-0851
immune system cancer8.21e-0851


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.